Koers Avacta Group Plc London S.E.
Aandelen
GB0033519546
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- GBX | - |
Omzet 2023 | 23,25 mln. 29,61 mln. 27,29 mln. | Omzet 2024 * | 24,5 mln. 31,21 mln. 28,77 mln. | Marktkapitalisatie | 157 mln. 200 mln. 184 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -24 mln. -30,57 mln. -28,18 mln. | Nettowinst (verlies) 2024 * | -27 mln. -34,39 mln. -31,7 mln. | EV/omzet 2023 | 14 x |
Nettoliquiditeiten 2023 * | 16,2 mln. 20,63 mln. 19,02 mln. | Nettoliquiditeiten 2024 * | 3,01 mln. 3,84 mln. 3,54 mln. | EV/omzet 2024 * | 6,27 x |
K/w-verhouding 2023 |
-12,7
x | K/w-verhouding 2024 * |
-5,68
x | Werknemers | - |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 70,66% |
Recentste transcriptie over Avacta Group Plc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Tony Gardiner
DFI | Director of Finance/CFO | 53 | 04-01-16 |
Matt Johnson
CTO | Chief Tech/Sci/R&D Officer | - | 16-09-13 |
Michael Vinegrad
IRO | Public Communications Contact | - | 01-06-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Trevor Nicholls
BRD | Director/Board Member | 67 | 02-08-13 |
Tony Gardiner
DFI | Director of Finance/CFO | 53 | 04-01-16 |
Paul Fry
BRD | Director/Board Member | 58 | 03-02-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,30% | 116 mld. | |
+12,15% | 106 mld. | |
-8,14% | 23,89 mld. | |
-1,69% | 21,58 mld. | |
-10,60% | 18,96 mld. | |
-41,25% | 16,96 mld. | |
-15,33% | 16,33 mld. | |
+5,80% | 14,14 mld. | |
+28,03% | 12,02 mld. |
- Beurs
- Aandelen
- Koers AVCT
- Koers